Our Services
Medical Information
Helpful Resources
Published on: 6/16/2026
BNP and NT-proBNP are hormones your heart releases when under stress. Elevated levels indicate ventricular strain and help doctors diagnose heart failure, guide treatment decisions and estimate the risk of complications. However, these values are influenced by age, kidney function, obesity and arrhythmias, so results must be interpreted alongside symptoms, medical history and other tests.
Because BNP and NT-proBNP results rarely tell the full story on their own, pairing them with a clear understanding of your symptoms is essential. Take a free, instant, online symptom check to better understand what your body is telling you and confidently navigate your next steps with your doctor.
Reviewed for medical accuracy: 06/16/2026
When you visit the doctor with symptoms such as shortness of breath, swelling in the legs or fatigue, blood tests for BNP (B-type natriuretic peptide) and NT-proBNP (N-terminal pro B-type natriuretic peptide) are often ordered. These tests help your healthcare team understand how well your heart is pumping and whether stress on your heart muscle may indicate heart failure.
Below is a clear guide to what BNP and NT-proBNP measurements actually tell your doctor—and what they mean for you.
• BNP (B-type natriuretic peptide):
– A hormone released by the heart’s ventricles when they’re stretched by excess fluid or pressure.
– Acts to reduce blood volume and blood pressure by causing blood vessels to widen and the kidneys to excrete more salt and water.
• NT-proBNP (N-terminal pro B-type natriuretic peptide):
– An inactive fragment produced at the same time as BNP.
– Circulates longer in the blood, making it a stable marker for testing.
Both markers rise when the heart is under strain. Your doctor may order one or both tests to evaluate heart function.
Measuring BNP levels provides a quick snapshot of how much stress your heart is under. Key reasons to check BNP or NT-proBNP include:
Diagnosing Acute Heart Failure:
Rapid testing in the emergency department helps distinguish heart failure from other causes of breathlessness, such as lung disease.
Assessing Severity:
Higher BNP or NT-proBNP levels generally indicate more severe heart strain.
Guiding Treatment:
Trends in peptide levels over time help doctors tailor medications (like diuretics, ACE inhibitors or beta-blockers) and decide if hospitalization is needed.
Prognosis and Risk Stratification:
Persistently elevated levels may signal a higher risk of hospital readmission or complications.
Reference ranges can vary slightly by lab, age and kidney function. As a general guide:
BNP Levels
400 pg/mL: Heart failure likely
NT-proBNP Levels
1,800 pg/mL (ages > 75): High risk
These cut-offs are guidelines. Your doctor interprets results alongside your history, symptoms and other tests (like an electrocardiogram or echocardiogram).
BNP and NT-proBNP levels don’t solely reflect heart failure. Several factors can raise or lower these values:
Factors that may raise levels:
Factors that may lower levels:
Because of these variables, your doctor uses BNP levels as one piece in a larger diagnostic puzzle.
Emergency Diagnosis:
In acute settings, if a patient presents with worsening shortness of breath and BNP levels are low (< 100 pg/mL), heart failure is unlikely and other causes (asthma, COPD, pneumonia) are explored.
Monitoring Chronic Heart Failure:
Serial measurements help track disease progression. A rising trend might prompt medication adjustments or closer follow-up.
Therapy Guidance:
Some studies suggest targeting BNP or NT-proBNP levels can improve outcomes by ensuring adequate therapy.
Risk Assessment Before Procedures:
Elevated levels pre-surgery can signal higher cardiac risk, leading to extra precautions.
An elevated BNP or NT-proBNP result does not diagnose heart failure on its own. Here’s how to think about it:
• Mild Elevation (BNP 100–400 pg/mL):
– Could reflect early heart strain, mild fluid retention or other heart conditions.
– Your doctor may order an echocardiogram or adjust medications.
• Marked Elevation (BNP > 400 pg/mL):
– Often indicates significant fluid overload and ventricular stretch.
– Usually leads to prompt treatment with diuretics, vasodilators or both.
• Very High NT-proBNP (> 1,800 pg/mL in older adults):
– Signals higher risk of hospitalization or complications.
– May warrant closer monitoring and possible referral to a heart specialist.
No test is perfect. Consider these limitations:
• False Positives:
– Kidney disease or lung disorders can raise levels without true heart failure.
• False Negatives:
– Very early heart failure or obesity can keep peptide levels deceptively low.
• Laboratory Variability:
– Different assays and machines can yield slightly different results.
Doctors always combine peptide levels with clinical examination, imaging and other blood tests to form a complete picture.
If you experience symptoms like persistent shortness of breath, sudden weight gain, swelling in the ankles or chest discomfort:
BNP and NT-proBNP tests are powerful tools, but they don’t replace a thorough clinical evaluation. If you have worrisome symptoms or abnormal test results, speak to your healthcare provider right away. Only a trained professional can determine the best course of action for anything potentially life-threatening or serious. Never ignore chest pain, severe breathlessness or sudden swelling—seek medical attention promptly.
(References)
* Fonarow GC, Pang PS, Anker SD, Butler J, Januzzi JL Jr, Packer M, Lam CSP. Natriuretic Peptides for Diagnosis and Management of Heart Failure: a Clinician's Guide. Curr Heart Fail Rep. 2022 Dec;19(6):353-364. doi: 10.1007/s11897-022-00570-5. PMID: 36201314.
* Cappelletti S, Calvello R, Pindozzi S, Bressi E, Carbone F, Scionti L, D'Urbano M, Cacciotti L, Carbone I, Ciavarella A, Del Giudice R, Gallo G, Di Stasio E, Capodanno D, Del Giudice R. NT-proBNP-Guided Therapy in Heart Failure: Current Evidence and Future Perspectives. J Clin Med. 2023 Mar 14;12(6):2268. doi: 10.3390/jcm12062268. PMID: 36983344.
* Januzzi JL Jr, van Kimmenade R, Kao P, Chen AA. B-Type Natriuretic Peptides: A Review of Clinical Relevance and Limitations. J Card Fail. 2019 Jul;25(7):448-459. doi: 10.1016/j.cardfail.2019.04.004. PMID: 31085203.
* Mueller C. The clinical utility of natriuretic peptides in heart failure. Clin Biochem. 2019 Apr;66:1-12. doi: 10.1016/j.clinbiochem.2019.01.002. Epub 2019 Jan 8. PMID: 30852030.
* Zegkos T, Karagiannis G, Mitrousi K, Karagiannopoulou A, Tziomalos K, Papadopoulos S. Natriuretic Peptides for the Diagnosis and Prognosis of Heart Failure. J Card Fail. 2021 Jan;27(1):122-132. doi: 10.1016/j.cardfail.2020.09.006. Epub 2020 Sep 17. PMID: 33402434.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.